Introduction: Morbid obesity is a serious health condition. Surgical interventions play an essential role in treatment, and sleeve gastrectomy is one of the most widely performed bariatric surgical procedures. After bariatric surgery, some patients may require reoperation for several reasons, such as complications, cholelithiasis, and gastroesophageal reflux. This study is an examination of the indications for reoperation and the results observed in patients who underwent reoperation following sleeve gastrectomy.
Introduction
Morbid obesity is one of the most serious diseases in the world. [1] [2] [3] Morbid obesity refers to body mass index (BMI) levels of 40 kg/m 2 or higher. [4] Morbid obesity is a risk factor for many systemic diseases such as diabetes, cardiopulmonary diseases and deep vein thrombosis. [5] The effectiveness of diet, exercise and medical treatments are limited for the treatment of morbid obesity. Bariatric surgery is becoming increasingly important for the treatment of morbid obesity. [3, 6] Roux-en-Y Gastric Bypass (RYGB) is a safe procedure that has proven its effectiveness for the treatment of morbid obesity for many years. Due to its technical difficulties, alternative surgical procedures to RYGB have been developed recently. Laparoscopic sleeve gastrectomy (LSG), which was previously used as a part of biliopancreatic diversion surgeries, has become a surgical procedure that is now performed alone for the treatment of morbid obesity. [2] It is getting more popular because there is no anastomosis construction and it is easier to apply than the other procedures. Despite the low rates of complications, complications such as bleeding and leak may be seen at times. Some of these complications can only be controlled by reoperation. This study aims to present the results of the cases that were reoperated after sleeve gastrectomy.
Materials and Methods
The patients, who were followed-up for morbid obesity at Elazığ Medical Park Hospital General Surgery Clinic between January 2016 and February 2019, were investigated retrospectively. The patients, who had surgical indications and underwent sleeve gastrectomy, were evaluated through the hospital database. The cases who were not reoperated after sleeve gastrectomy were excluded from the study (Fig. 1) . The patients who were reoperated for various reasons after sleeve gastrectomy were included in the study (Fig. 2 ). Demographic characteristics of the patients, indications and results of reoperation were analyzed.
Ethics committee approval and informant consent were not obtained due to the retrospective design of the study. In addition to that, the study was carried out in accordance with the ethical principles of the World Medical Association's Declaration of Helsinki.
Statistics
Statistical analysis was performed by using the SPSS Statistics software package, version 20 (IBM Corp. in Armonk, NY). Descriptive data were presented as frequencies (n) and percentages (%) for categorical variables and as mean with standard deviation or median with (min-max range). for non-normal distributed numerical variables.
Results
The patients, who underwent sleeve gastrectomy for morbidity obesity in Elazığ Medical Park Hospital between December 2016 and February 2019, were investigated retrospectively through the hospital database. One thousand two hundred and sixty eight patients were determined who underwent sleeve gastrectomy due to obesity. Patients who were followed up conservatively, who had interventional radiology procedures or underwent endoscopic stenting without surgical drainage were excluded from the study. Fifteen cases that were reoperated after Laparoscopic Sleeve Gastrectomy (LSG) were included in the study. Overall reoperation rate after sleeve gastrectomy was 1.18%. Seven of the patients were female and eight of them were male. The mean age was 37.26 (±7.95). The mean BMI of reoperated patients was 45.67 (±3.64). One case was reoperated due to bleeding in the 6th hour postoperatively. Surgical drain was placed in a patient due to intra-abdominal fluid collection on the 6th day postoperatively. Catheter was inserted surgically in 4 of the 10 cases who developed leak. In 3 of these cases, leaks were closed after conservative follow-up and one of the cases required endoscopic stenting. RYGB procedure was performed to the patient who developed stenosis after sleeve gastrectomy. Two cases were reoperated due to incisional hernia. Six cases underwent laparoscopic cholecystectomy due to symptomatic cholelithiasis (Table 1) . No additional intervention was required for other cases except the case who had endoscopic stenting after the leak. No complications were observed related to the second operations.
Discussion
Sleeve gastrectomy is one of the most widely performed procedures in bariatric surgery. The similar surgical results compared to the other techniques, low complication rates and relatively easier application make this technique effective and reliable. [7] The overall complication rate in large medical centers is <15%. [8] Khoursheed et al. [9] reported their overall complication rate was 7.5%. The most serious complications after sleeve gastrectomy are bleeding and leak. [8] Bleeding ratio after sleeve gastrectomy is 1 to 2%. Some patients may require blood transfusion and/ or re-exploration. [9] Khoursheed et al. [9] reported reopera- 
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h e r n i a tion rate as 0.5% due to bleeding. In this study, one case was reoperated due to bleeding in the 6th hour postoperatively. Surgical drain was placed in a patient due to intraabdominal fluid collection on the 6th day postoperatively. Postoperative staple line leak was reported to occur in 0-6.7% of patients in systematic reviews. [9] Catheter was inserted surgically in 4 patients who developed leak. In 3 of these cases, leaks were closed after conservative followup and a case required endoscopic stenting.
The leak rates after sleeve gastrectomy were reported in various rates in the literature, but they are generally low. [8, 10, 11] Sleeve Gastrectomy Expert Panel Consensus Statement 2011, the leak rate was 1.06%. [12] Surgical intervention may be necessary in cases that cannot be conducted conservatively. The overall leak rate was observed to be 0.78% in our study. Surgical catheter was inserted in 40% of the cases that developed a leak and were followed up conservatively. No major revision surgery was performed in any case due to leak. One case was required endoscopic stent procedure after surgical drain catheterization.
There is no clear information in the literature about the incidence of cholelithiasis after sleeve gastrectomy. Rapid weight loss after bariatric surgery is regarded as responsible for the formation of cholelithiasis. [13] The incidence of symptomatic gallstones requiring cholecystectomy after laparoscopic sleeve gastrectomy (LSG) was reported as 0.9-7.5% in the literature. [13] In follow-ups of the 1268 cases operated in this study, symptomatic cholelithiasis was detected in 6 cases (0.47%). Cholelithiasis was not known preoperatively in these patients. The earliest case was in the 4 th month and the latest case was in the 3 nd year.
In the literature, approximately 5-10% of SG patients have been reported to require revision procedures. [7] Yorke et al. [7] reported conversion rates as 6.6%. RYGB procedure was performed to one patient who developed stenosis after sleeve gastrectomy in this study (0.07%). Revision rates are low compared with the literature. However, no patients underwent revision because of insufficient weight loss.
While morbid obesity causes many systemic diseases, it significantly reduces the surgical risk for the patient group who need elective surgery. After bariatric surgery, some of the patients can be reoperated due to complications such as cholelithiasis, gastroesophageal reflux. This study reveals that additional surgical interventions can be performed safely after sleeve gastrectomy.
There are some limited aspects of this study. The retrospective design of the study and the limited number of reoperated patients are the limited aspects of this study. However, when we look at the literature, the results are similar to this study in terms of the reoperation rates.
Conclusion
Morbid obesity is one of the most serious diseases. Sleeve gastrectomy has become the most commonly used procedure for the treatment of morbid obesity. Some patients need additional surgical procedures after sleeve gastrectomy. Additional surgical procedures can be performed safely for these patients.
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